Roche Eyes Adjuvant HCC Setting After Phase III Tecentriq Combination Success

But Market Opportunity Limited

 
• By Ayisha Sharma
  
Hand holding a luminated liver shape
There Are Around 10,000 HCC Patients Diagnosed Each Year • Source: Shutterstock

More from Clinical Trials

More from R&D